Academic Drug Discovery - part of Cambridge Workshop Series

SELECTBIO has been given the great honour of hosting a workshop on Academic Drug Discovery at Buckingham House, Murray Edwards College, Cambridge University.

Agenda Topics:
- Drug discovery technology transfer
- European lead generation and enabling open innovation
- Novel approaches across different therapeutic areas
- Partnering models for academia and industry
- Professional translational research

+ show speakers and program
Keynote Speakers:
- Sir Tom Blundell, Group Leader, University of Cambridge
- Stephen Frye, Director of The Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina
- Marcie Glicksman, Co-Director, Harvard NeuroDiscovery Center and Brigham and Women's Hospital

Other Confirmed Speakers:
- Tim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology, UK
- Julian Blagg, Deputy Director, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research
- Roland Wolkowicz, Associate Professor, San Diego State University
- Maurizio Pellecchia, Professor, Sanford Burnham Medical Research Institute
- Susanne Muller-Knapp, Project Manager, University of Oxford
- Steve Rees, Vice President, Screening Sciences and Sample Management, AstraZeneca
- John Spencer, Reader in Chemistry, University of Sussex
- Peter Nussbaumer, Managing Director and Head of Medicinal Chemistry, Lead Discovery Center GmbH
- Phil Jones, Director, University of Dundee
- Mark Moloney, Professor of Chemistry, University of Oxford
- Patrick Chaltin, IP Manager - Director of Centre for Drug Design and Discovery, K.U.Leuven Research & Development

19 May - 20 May 2015

United Kingdom
meeting website